1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AVALO THERAPEUTICS INC
Avalo Therapeutics Inc XNAS: AVTX
6.54 -0.04 (-0.61%)
72,565
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Avalo Therapeutics Inc - AVTX - stock price prediction, stock price target, analyst ratings from 7 analysts

Avalo Therapeutics Inc has a share price target of US$ 31 and profit growth estimate of -70.1% for Unknown Year, based on top 7 analyst calls.